CLVR Stock Overview
Clever Leaves Holdings Inc. operates as a cannabis company.
Clever Leaves Holdings Inc. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$0.60|
|52 Week High||US$7.65|
|52 Week Low||US$0.58|
|1 Month Change||-24.92%|
|3 Month Change||-37.94%|
|1 Year Change||-91.97%|
|3 Year Change||-94.00%|
|5 Year Change||n/a|
|Change since IPO||-93.76%|
Recent News & Updates
Clever Leaves partners with House of Kush for international expansion
Clever Leaves (NASDAQ:CLVR) partners with U.S. cannabis-branded genetic innovation company, House of Kush, to be the exclusive grower and distributor of proprietary genetics globally. The company will be the exclusive producer of various genetics for House of Kush outside of the United States and Canada. It will cultivate and commercialize House of Kush proprietary genetics in its Colombia and Portugal facilities for the duration of the three-year agreement, after completing an initial evaluation and adaptation phase of the genetics for each production location. This partnership will further strengthen the company's portfolio of high THC smokable flower which is already being sold in Germany, Israel, and Australia. Andres Fajardo, Clever Leaves’ CEO, stated, “The strategic partnership with House of Kush leverages both companies core capabilities. On the one hand, it will allow Clever Leaves to further expand its flower portfolio with globally renowned genetics. On the other hand, it will serve as a platform for House of Kush to expand their coverage beyond the United States and Canada. Together we will be able to bring high quality product to patients at a global level on a consistent basis.”
Clever Leaves reports Q2 results
Clever Leaves press release (NASDAQ:CLVR): Q2 Revenue of $4.7M (+28.1% Y/Y) misses by $0.85M. Based on sustained commercial momentum across its target markets, the Company continues to expect its full year 2022 revenue to be within the range of $20 million and $25 million, with adjusted gross margin expected to range between 50% and 55%. Clever Leaves also expects adjusted EBITDA to range between $(23) million and $(20) million. In addition, the Company expects approximately $2 million to $3 million of annual capital expenditures.
|CLVR||US Pharmaceuticals||US Market|
Return vs Industry: CLVR underperformed the US Pharmaceuticals industry which returned 3.2% over the past year.
Return vs Market: CLVR underperformed the US Market which returned -23.2% over the past year.
|CLVR Average Weekly Movement||14.5%|
|Pharmaceuticals Industry Average Movement||11.3%|
|Market Average Movement||6.8%|
|10% most volatile stocks in US Market||15.5%|
|10% least volatile stocks in US Market||2.8%|
Stable Share Price: CLVR is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 14% a week.
Volatility Over Time: CLVR's weekly volatility has decreased from 26% to 14% over the past year, but is still higher than 75% of US stocks.
About the Company
Clever Leaves Holdings Inc. operates as a cannabis company. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment engages in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products internationally.
Clever Leaves Holdings Inc. Fundamentals Summary
|CLVR fundamental statistics|
Is CLVR overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|CLVR income statement (TTM)|
|Cost of Revenue||US$11.86m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.93|
|Net Profit Margin||-221.98%|
How did CLVR perform over the long term?See historical performance and comparison